Prudential Financial Inc. trimmed its position in Hill-Rom Holdings Inc (NYSE:HRC) by 16.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 454,924 shares of the medical technology company’s stock after selling 90,862 shares during the quarter. Prudential Financial Inc. owned approximately 0.69% of Hill-Rom Holdings worth $33,665,000 as of its most recent SEC filing.
Several other hedge funds have also recently modified their holdings of the company. American Century Companies Inc. raised its holdings in shares of Hill-Rom Holdings by 385.0% in the 3rd quarter. American Century Companies Inc. now owns 535,229 shares of the medical technology company’s stock valued at $39,607,000 after purchasing an additional 424,870 shares during the period. Stevens Capital Management LP raised its holdings in shares of Hill-Rom Holdings by 11.4% in the 3rd quarter. Stevens Capital Management LP now owns 13,370 shares of the medical technology company’s stock valued at $989,000 after purchasing an additional 1,369 shares during the period. Old Mutual Global Investors UK Ltd. bought a new stake in shares of Hill-Rom Holdings in the 3rd quarter valued at about $939,000. Brookstone Capital Management raised its holdings in Hill-Rom Holdings by 18.0% in the 3rd quarter. Brookstone Capital Management now owns 4,280 shares of the medical technology company’s stock valued at $317,000 after acquiring an additional 652 shares during the period. Finally, Crossmark Global Holdings Inc. bought a new position in Hill-Rom Holdings in the 3rd quarter valued at about $638,000. 82.05% of the stock is currently owned by institutional investors.
Hill-Rom Holdings Inc (NYSE:HRC) opened at $76.73 on Tuesday. Hill-Rom Holdings Inc has a 52-week low of $52.58 and a 52-week high of $84.65. The stock has a market cap of $5,018.79, a P/E ratio of 19.74, a price-to-earnings-growth ratio of 1.62 and a beta of 1.19. The company has a current ratio of 1.77, a quick ratio of 1.34 and a debt-to-equity ratio of 1.55.
Hill-Rom Holdings (NYSE:HRC) last announced its earnings results on Friday, November 3rd. The medical technology company reported $1.32 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.27 by $0.05. Hill-Rom Holdings had a net margin of 4.87% and a return on equity of 20.27%. The firm had revenue of $738.30 million for the quarter, compared to analyst estimates of $731.10 million. During the same quarter in the prior year, the business posted $1.18 EPS. The business’s revenue was up 4.6% compared to the same quarter last year. sell-side analysts expect that Hill-Rom Holdings Inc will post 4.26 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 29th. Shareholders of record on Friday, December 15th will be given a dividend of $0.18 per share. The ex-dividend date is Thursday, December 14th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.94%. Hill-Rom Holdings’s payout ratio is presently 36.18%.
Several research firms have weighed in on HRC. BidaskClub cut shares of Hill-Rom Holdings from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Zacks Investment Research raised shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $90.00 price target on the stock in a report on Friday, October 27th. Needham & Company LLC lowered their price target on shares of Hill-Rom Holdings from $95.00 to $93.00 and set a “buy” rating on the stock in a report on Friday, July 28th. KeyCorp reissued a “buy” rating and issued a $89.00 price target (up from $82.00) on shares of Hill-Rom Holdings in a report on Sunday, November 5th. Finally, Stifel Nicolaus increased their price target on shares of Hill-Rom Holdings from $84.00 to $85.00 and gave the company a “buy” rating in a report on Monday, November 6th. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $88.57.
In other Hill-Rom Holdings news, SVP Andreas G. Frank sold 6,870 shares of the stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $77.48, for a total transaction of $532,287.60. Following the transaction, the senior vice president now owns 16,701 shares in the company, valued at approximately $1,293,993.48. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Andreas G. Frank sold 3,940 shares of the stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $77.84, for a total transaction of $306,689.60. Following the transaction, the senior vice president now owns 16,701 shares in the company, valued at approximately $1,300,005.84. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.
About Hill-Rom Holdings
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.